Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: bob wallace who wrote (608)	11/24/1998 6:12:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 2539

Bob, Bloomberg does cover MTC very closely. Not a mention of this piece of news on Dow Jones (not even the premier service in my e-broker's site).

To: bob wallace who wrote (608)	11/24/1998 10:01:00 PM
From: Anthony Wong	Respond to of 2539

From today's Reuters US Options Report: Elsewhere on the CBOE, implied volatility on Dekalb Genetics Corp. (NYSE:DKB - news) options slipped to around 37 percent on the January 90 contracts from around 47 percent late on Monday. Traders attributed the drop to expectations that Dekalb's merger deal with Monsanto Co. (NYSE:MTC - news) would close soon. The January 90 and 95 calls on Dekalb registered volume of more than 600 contracts, compared with put volume of just 348 contracts. Monsanto late Monday priced a 22.5 million share offering at $40 per share as part of its plan to finance about $6 billion worth of planned acquisitions. Monsanto agreed to acquire the remaining 60 percent of Dekalb it did not already own. Rumblings last week that the deal might be in jeopardy had lifted implied volatility on Dekalb, traders said. biz.yahoo.com